Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Acute Kidney Injury, Acute Kidney Injury Due to Sepsis
Location: Fort Worth TX, Dallas TX, Houston TX, Birmingham AL,
Sponsor: SeaStar Medical
Sex: All
Age: 0 - 22
Code: NCT06517810
Recruiting
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
for
Medulloblastoma
Location: Fort Worth TX, Dallas TX, Houston TX, Memphis TN,
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 4
Code: NCT05535166
Phase 2, Recruiting
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
for
Spinal Muscular Atrophy (SMA)
Location: Fort Worth TX, San Antonio TX, Houston TX,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 0+
Code: NCT04174157
Recruiting
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
for
Refractory Acute Myeloid Leukemia,
Location: Fort Worth TX, Dallas TX, Memphis TN, Kansas City MO,
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 1 - 30
Code: NCT06177067
Phase 1, Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Fort Worth TX, Dallas TX, Austin TX, Oklahoma City OK,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT06401330
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Fort Worth TX, Atlanta GA, Indianapolis IN, Dayton OH,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 2 - 17
Code: NCT05923073
Phase 3, Recruiting
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
for
Dravet Syndrome
Location: Fort Worth TX, Aurora CO, Rochester MN, Chicago IL,
Sponsor: Encoded Therapeutics
Sex: All
Age: 0 - 17
Code: NCT05419492
Phase 1, Phase 2, Recruiting
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Fort Worth TX, Dallas TX, Oklahoma City OK,
Sponsor: Children's Oncology Group
Sex: All
Age: 2 - 18
Code: NCT05711667
Phase 3, Recruiting
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
for
Type 1 Diabetes
Location: Fort Worth TX, Dallas TX, San Antonio TX, Houston TX,
Sponsor: SAb Biotherapeutics, Inc.
Sex: All
Age: 5 - 40
Code: NCT07187531
Phase 2, Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Fort Worth TX, Dallas TX, Houston TX, Memphis TN,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 21
Code: NCT04870944
Phase 1, Phase 2, Recruiting
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
for
Neuroblastoma
Location: Fort Worth TX, Dallas TX, Memphis TN, Aurora CO,
Sponsor: New Approaches to Neuroblastoma Therapy Consortium
Sex: All
Age: 1 - 31
Code: NCT06450041
Phase 2, Recruiting
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
for
Locally Advanced Adrenal Cortical Carcinoma,
Location: Fort Worth TX, Dallas TX, Richardson TX, Austin TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT06900595
Phase 2, Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Location: Fort Worth TX, Dallas TX, Austin TX, Oklahoma City OK,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT03126916
Phase 3, Recruiting
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
for
Lymphoblastic Lymphoma, Acute Lymphoblastic Leukemia ALL
Location: Fort Worth TX, Houston TX, Aurora CO, Indianapolis IN,
Sponsor: Allterum Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT07586618
Phase 1, Recruiting
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
for
Spinal Muscular Atrophy, SMA, Spinal Muscular Atrophy Type 2,
Location: Fort Worth TX, Houston TX, Memphis TN, St Louis MO,
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0+
Code: NCT01120353
Recruiting
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
for
Eosinophilic Esophagitis (EoE)
Location: Fort Worth TX, Aurora CO, Atlanta GA, Phoenix AZ,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 0 - 6
Code: NCT07112378
Phase 3, Recruiting
Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age
for
Catheter-Related Infections
Location: Fort Worth TX, Birmingham AL, Phoenix AZ, Wilmington DE,
Sponsor: CorMedix Therapeutics
Sex: All
Age: 0 - 17
Code: NCT06714864
Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Fort Worth TX, Dallas TX, Austin TX, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase 2, Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Fort Worth TX, Dallas TX, Temple TX, Austin TX,